Business Wire

LESSENGERS Demonstrates 800G QSFP-DD and 400G QSFP112 Optical Transceivers

12.9.2022 13:00:00 EEST | Business Wire | Press release

Share

LESSENGERS Inc. (“LESSENGERS”), an innovative optical interconnect solution provider, announced today, a live demonstration of polymer-wired 800G QSFP-DD and 400G QSFP112 optical transceivers without the use of any lens optics, providing excellent performance and cost-effectiveness, during the ECOC 2022 (Stand 511 and MR31), the largest optical communications exhibition in Europe, on September 19 – 21, at Messe Basel, Switzerland.

Powered by LESSENGERS’s patent direct optical wiring (DOW) technology, the LESSENGERS 800G QSFP-DD and 400G QSFP112 optical transceivers achieve excellent optical signal integrity and best cost-effectiveness. This unique technology enables complete passive alignment with high-precision and -density optical coupling without the use of lens optics, providing the most suitable solutions for high-speed data center applications such as 800G/1.6T optical modules, on-board, near packaged or co-packaged optics.

“LESSENGERS will demonstrate a set of 112G and 56G signaling-based products during the show, ECOC 2022 on September 19 – 21 to support our customers in urgent needs and will be adding products in the upcoming quarters to complete its product portfolio,” said Taeyong Kim, CMO at LESSENGERS.

“LESSENGERS’s current business is focused on multimode-based optical interconnect solutions along with customized optical packaging services, however, we will continue to push forward on single-mode-based applications such as silicon photonics,” added Chongcook Kim, CEO at LESSENGERS. “This successful demonstration of DOW technology-based optical transceiver solutions will bring a new era of data center optical interconnects and the development of these technologies will support future requirements for high performance computing (HPC) and artificial intelligence (AI) solutions.

LESSENGERS’s demonstration will be with:

  • 800G QSFP-DD SR8 optical transceiver
  • 400G QSFP112 SR4 optical transceiver
  • 200G QSFP56 SR4 optical transceiver
  • 200G ultra-small sized optical module

About LESSENGERS

LESSENGERS Inc. is an innovative optical interconnect solution provider. Its patent direct optical wiring (DOW) technology enables high-precision and high-density submicrometer scale optical coupling between high-speed photonic devices and various optical waveguides with the best cost-effectiveness. LESSENGERS’s 800G/400G/200G optical transceiver/active optical cable solutions are powered by the high-performance manufacturing-oriented DOW technologies.

Please visit www.lessengers.com for more information.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

LESSENGERS Inc.
Taeyong Kim, Ph.D
Chief Marketing Officer
+82-10-6549-7654
taeyong.kim@lessengers.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Lattice to Showcase Industrial FPGA Innovations at FPGAWorld Conference 202625.8.2026 23:00:00 EEST | Press release

Lattice Semiconductor (NASDAQ: LSCC), the low power programmable and platform firmware leader, today announced its exhibition plan for the upcoming FPGAWorld Conference 2026, taking place on Sept. 8, 2026, in Stockholm, Sweden. As part of the event, Lattice will deliver technical presentations and host a demo showcase focused on how its low power FPGA solutions are advancing Industrial IoT and sensor bridging applications. Who: Lattice Semiconductor What / When (GMT+2): Tuesday, Sept. 8, 2026 Lattice Demo Showcase Presentations (Track: 12:20 – 13:35, Room Brave 05) “Solving Your Power Puzzle: Lattice FPGAs’ Path to Uncompromised Low Power” “Practical Security Fundamentals for FPGA Engineers” Where: AFRY, Frösundaleden 2A, 169 70 Solna, Sweden The FPGAWorld Conference is an international forum for researchers, engineers, teachers, students, and hackers. It covers topics such as complex analog/digital/software FPGA SoC systems, FPGA/ASIC-based products, educational and industrial cases,

France Becomes First Official Participant at Expo 2030 Riyadh25.8.2026 20:40:00 EEST | Press release

France is the first country to officially sign its Participation Contract for Expo 2030 Riyadh, a major milestone in its preparations and growing international momentum. The signing took place on the sidelines of the visit to France by His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260825634516/en/ The ceremony in Paris was attended by H.H. Prince Faisal bin Farhan Al Saud, Minister of Foreign Affairs of the Kingdom of Saudi Arabia, and Dimitri S. Kerkentzes, Secretary General of the BIE. The Participation Contract was signed by Talal Al-Marri, Chief Executive Officer of Expo 2030 Riyadh, and Jacques Maire, Chairman of the Compagnie Française des Expositions (COFREX). The agreement formally establishes France’s participation in Expo 2030 Riyadh, providing the framework for its presence throughout the six-month event. It spec

Saudi Arabia and BIE Sign See Agreement for Expo 2030 Riyadh, Advancing Framework for International Participation25.8.2026 20:17:00 EEST | Press release

The Kingdom of Saudi Arabia and the Bureau International des Expositions (BIE) have signed the See Agreement for Expo 2030 Riyadh, formally establishing the legal and administrative framework that will support Official Participants throughout their journey to the World Expo. The signing took place on the sidelines of the visit to France by His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260825419959/en/ H.H. Prince Faisal bin Farhan Al Saud, Minister of Foreign Affairs of the Kingdom of Saudi Arabia, and Dimitri S. Kerkentzes, Secretary General of the BIE, at the ceremony. The ceremony was attended by H.H. Prince Faisal bin Farhan Al Saud, Minister of Foreign Affairs of the Kingdom of Saudi Arabia, Dimitri S. Kerkentzes, Secretary General of the BIE, and Talal Al-Marri, CEO of Expo 2030 Riyadh. The See Agreement sets out the

The LYCRA Company Reimagines the Trade Show Experience at Intertextile25.8.2026 19:11:00 EEST | Press release

The LYCRA Company, a global leader in fiber and technology solutions for the apparel industry, is reimagining the trade show experience at Intertextile Shanghai Apparel Fabrics Autumn Edition, which opened today in China. Building on the success of last year's ALL IN concept, the company has expanded its co-creation vision into a 356-square-meter Lifestyle District featuring partners Jingzili New Material, JYT Textile, Lianxingfa Knitting, and Trend Textile. The district is part of a larger 895-square-meter pavilion showcasing a total of 19 co-exhibitors. Together, they demonstrate how innovations in fiber, fabric, and garments can be combined to create compelling solutions for both work and play. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260821281698/en/ The LYCRA Company expands its co-creation vision through an immersive Lifestyle District at Intertextile Shanghai. “The apparel industry is built on creativity, and gr

BeOne Medicines Announces U.S. FDA Approval for TEVIMBRA-Based Regimen for First-Line HER2+ GEA25.8.2026 17:40:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for TEVIMBRA® (tislelizumab) in combination with ZIIHERA® (zanidatamab) and chemotherapy for the first-line treatment of adult patients with unresectable locally advanced or metastatic HER2-positive (HER2+) gastric, gastroesophageal junction, or esophageal adenocarcinoma (GEA). The approval is supported by results from the Phase 3 HERIZON-GEA-01 trial, which were published in The New England Journal of Medicine earlier this year. GEA, which includes adenocarcinomas of the stomach, gastroesophageal junction and esophagus, remains an area of substantial unmet need in the United States, with more than 31,000 new stomach cancer cases diagnosed each year.1 Approximately 20% of patients with GEA have HER2+ disease, a subtype that has historically been difficult to treat.2,3,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye